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Abstract
A new species of parvovirus tentatively named human bocavirus 4 (HBoV4) was genetically
characterized. Among 641 feces samples from children and adults the most commonly detected
bocaviruses species were HBoV2>HBoV3>HBoV4>HBoV1 with HBoV2 prevalence of 21% and
26% in Nigerian and Tunisian children. HBoV3 and HBoV4 species combined were found in 12/192
cases of non-polio acute flaccid paralysis (AFP) from Tunisia and Nigeria and 0/96 healthy Tunisian
contacts (p=0.01). Evidence of extensive recombination at the NP1 and VP1 gene boundary between
and within species was found. The multiple species and high degree of genetic diversity seen among
the human bocaviruses found in feces relative to the highly homogeneous HBoV1 suggest that this
world-wide distributed respiratory pathogen may have recently evolved from an enteric bocavirus,
perhaps after acquiring an expanded tropism favoring the respiratory track. Elucidating the possible
role of the newly identified enteric bocaviruses in human diseases including AFP and diarrhea will
require further epidemiological studies.
INTRODUCTION
Parvoviruses are small, non-lipid enveloped, environmentally resistant viral particles with
single- stranded linear DNA genomes that frequently infect animals through the fecal–oral
route (1). Parvoviruses can cause numerous symptoms in animals, including enteritis,
panleukopenia, hepatitis, erythrocyte aplasia, and cerebellar ataxia (1). Efficacious vaccines
against animal parvovirus infections are widely employed (2–4).
Following the identification of the human parvovirus B19 in 1976 several other human
parvoviruses have recently been genetically characterized. PARV4 was found in the blood of
Reprints or correspondence: Eric Delwart, Blood Systems Research Institute, 270 Masonic Ave., San Francisco, CA 94118. Tel:
415-9235763, Efax: 419-7914220, delwarte@medicine.ucsf.edu.
•Communicating author: Blood Systems Research Institute, 270 Masonic Ave, San Francisco CA 94118. delwarte@medicine.ucsf.edu
Tel: 415-9235763 Fax: 415-5675899
Conflict of interest: A provisional patent application has been filed for HBoV2-3-4.
NIH Public Access
Author Manuscript
J Infect Dis. Author manuscript; available in PMC 2011 June 1.
Published in final edited form as:
J Infect Dis. 2010 June 1; 201(11): 1633–1643. doi:10.1086/652416.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
an adult intravenous drug user (5), HBoV1 in the nasopharyngeal secretion of a child with
respiratory problems (6), HBoV2 in the stool of children with non-polio acute flaccid paralysis
(7), and HBoV3 in the stool of Australian children with diarrhea (8). In contrast to PARV4 or
B19, bocaviruses contain a third open reading frame of unknown function (10)(11).
The first bocavirus identified was in cows (12), and the name of the genus is derived from its
first known hosts (bovine-canine). Animal bocaviruses can cause both respiratory and gastro-
intestinal diseases and embryonic and fetal death (10).
HBoV1 infection has been linked with mild to severe, primarily lower respiratory tract
infections in children, frequently in association with other viral infections (11)(13)(14)(15)
(17)(18)(19)(20)(21)(22)(23)(25)(26)(27)(28). HBoV1 has also been detected at low
frequency in stool samples although association with diarrhea appears weaker than with
respiratory symptoms (11)(29)(30)(31)(32)(33)(34). HBoV1 strains show a very low degree
of genetic variability world-wide (35,36). HBoV2 was recently identified in stool samples of
Pakistani children (7). Lower frequencies of HBoV2 were detected in the stool of Scottish
adults and children (7). A third bocavirus species, HBoV3, as well as HBoV2, were recently
found in stool samples from Australian children with diarrhea (8).
In this study, pan-bocavirus PCR primers were designed and used on human stool samples
from several countries. All three recently identified bocaviruses plus a fourth species, HBoV4,
were identified. A high degree of genetic diversity, relative to that seen for HBoV1, was seen
among human bocaviruses in feces.
MATERIALS AND METHODS
Samples
Stool samples were collected as part of previous clinical studies and anonymized. This study
was approved by the UCSF CHR. Samples from Nigeria and Tunisia were collected as part of
the WHO’s poliovirus eradication program from children with non-polio AFP between the
ages of 4 months and 15 years. Stool samples from healthy contacts of cases from Tunisia were
matched for age. Stool samples from Nepal were from adult travelers and resident expatriates
with diarrhea with no known enteric pathogens detected following standard microbiology for
enteric bacteria, EIA for rotavirus, adenovirus, astrovirus, Giardia and Cryptosporidium and
RT-PCR for norovirus. Stool samples from healthy, asymptomatic controls were collected
from the same population. Stool samples from the Minnesota Department of Health are from
individuals with diarrhea and healthy individuals, matched for age and residential area code.
PCR amplification of bocaviruses
We used nested PCR targeting the VP1/2 region of both HBoV1 and HBoV2 (nucleotide
positions 3233 to 3808 numbered here and subsequently using the HBoV2 prototype sequence
GenBank entry FJ170278). Nucleic acids (DNA and RNA) was extracted (QIAamp Viral RNA
mini kit) from 140 µl of clarified stool supernatant and eluted into 60 µl of water. First-round
PCR primers were AK-VP-F1:(CGCCGTGGCTCCTGCTCT) and AK-VP-R1:
(TGTTCGCCATCACAAAAGATGTG) and second-round primers were AK-VP-F2:
(GGCTCCTGCTCTAGGAAATAAAGAG) and AK-VP-R2:
(CCTGCTGTTAGGTCGTTGTTGTATGT). PCR contained 2.5U of Taq DNA polymerase
(NEB) in 1.1×Thermopol reaction buffer with MgCl (2.0mM), 20pmol (each) of forward and
reverse primers, and 2.5 µl of nucleic acids (first round) or 1µl of the first-round PCR product
(second round) as template in 50ul PCRs. First-round conditions were 10 cycles of 95°C for
35 sec, 58°C for 1 min, and 72°C for 1 min, with a decrease of 0.5°C in annealing temperature
each cycle; 30 cycles of at 95°C for 30 sec, 54°C for 45 sec, and 72°C for 45 sec; a final
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extension at 72°C for 10 min. Similar conditions were used for the second round, except that
the initial annealing temperatures were 60°C and 58° in the first and second group of PCR
cycles, respectively. Amplicons of the appropriate size detected by agarose gel electrophoresis
were directly sequenced. The PCR products whose sequences are reported here produced
unambiguous dideoxy-sequencing electrophoregram peaks indicating the predominance
(>90%) of a single bocavirus variant. The sensitivity of the pan-bocavirus nested PCR was
determined using dilution of plasmids containing the target sequences from each of the four
bocavirus species and was estimated at 10–100 plasmid copies for each species.
Complete genome sequencing
Complete genomes were amplified using PCR primers designed from alignments of HBoV1
and HBoV2 genomes and then directly sequenced by primer walking (7). The terminal
sequences were acquired by a modified protocol for rapid amplification of cDNA ends (5).
The terminal sequences are incomplete because of extensive hairpin structures preventing
extensions to the viral 5’ and 3’ extremities.
Distance measurements and phylogenetic analyses
Phylogenetic relationships were evaluated by using Mega 4.1
(http://www.megasoftware.net/mega41.html) (37). Neighbor-joining trees were inferred using
a matrix of pairwise maximum-likelihood distances computed from a nucleotide alignment
including the genomes obtained in this study and in Genbank plus a matrix of PAM distances
computed from the inferred amino acid alignment.
Recombination analyses
Similarity values based on Jukes-Cantor corrected nucleotide distances between full-length
sequences were calculated using the program SequenceDist in the Simmonic2005 v1.6
Sequence Editor Package (38). To assess similarity across the genomes, sequence scans were
performed using a fragment length of 300 bases and an increment of 9 bases between fragments.
For sequence comparisons with HBoV-1 and HBoV2, a mean pairwise distance was computed
using a set of 14 HBoV1 and 7 HBoV2A sequences (as shown in Fig. 2).
Nucleotide sequence accession numbers
The near full genomes and partial VP1 gene sequences have been deposited in GenBank under
accession numbers FJ973558-FJ973563 and GQ506558-GQ506661
RESULTS
Wide spread geographic distribution of human bocaviruses and identification of new species
Pan-bocavirus PCR primers were designed that could anneal to both HBoV1 and HBoV2
amplifying a fragment approximately 576 nt long of the VP1 capsid gene (see Materials and
Methods). Nucleic acids from human stools collected from Nigeria, Tunisia, Nepal and the
United States were then analyzed using nested PCR (Table 1). Of the 641 samples tested, 101
(16%) were confirmed positive by PCR sequencing, with the highest prevalence in Tunisian
children with AFP (33%). To determine the phylogenetic relationship of these strains, the
sequences were aligned with available sequences of HBoV1, 2, and 3. Only 4/101 strains (from
Nigeria and Tunisia) grouped with HBoV1. The remaining strains shared a more recent
common ancestry with HBoV2, although the sequences clustered into four distinct genetic
lineages, labeled HBoV2A, HBoV2B, HBoV3, HBoV4 (Fig. 1).
The HBoV2A clade included all three published HBoV2 genotypes (7), plus four new strains
from Nigeria and Tunisia and the recently reported W153 strain from Australia (8). Because
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of the high degree of genetic diversity observed and to prevent excessive splitting of HBoV2
into a multitude of genotypes, all strains in that cluster were re-classified into a new, now more
diverse genotype A (HBoV2A). The nearly full genome of a new HBoV2A variant was
sequenced (TU-C-114-06) and showed very high protein identities (>98%) to the Pakistani
HBoV2 prototype PK5510 (FJ170278).
The HBoV2B cluster included 76 of the 101 bocavirus strains reported here. Two near full
genomes were sequenced showing pair-wise amino acid divergence in VP1 of 0.45% (Table
2B)(NI-213 and NI-327)(Genbank accession: FJ973560 and FJ973559). Greater divergence
was observed when these strains were compared to the VP1 of HBoV2A strains (average 3.9%
range 3.3%–4.5%)(Table 2C). The nucleotide and amino acid distances at the other loci are
shown (Table 2C). Using the amino acid divergence between VP1 proteins as the criterion for
genotype level classification, this cluster was therefore labeled as HBoV2 genotype B
(HBoV2B). The large majority (76/101) of HBoV variants identified in this study belonged to
the HBoV2B genotype (Table 1).
The HBoV3 cluster included 11 strains, and the complete genomes of two representative
strains, NI-374 and TU-A-210-07, were acquired (Genbank accession: FJ973563 and
FJ973562). When compared to HBoV2, the NS1 region of both strains showed an average
amino acid divergence of 26% in the NS1 region and 9% in the VP1 region. Compared to
HBoV1, the HBoV3 strains showed an average amino acid divergence of 12% in the NS1
region and 20% in the VP1 region (Table 2C). All 11 strains were classified as members of the
new HBoV3 species recently described by Arthur et al (8). A distantly related variant of HBoV3
was also recently identified in a US sewage sample (Fig 1 HBoV3B-CA-1-C1)(39). To confirm
that this variant represents a second genotype of HBoV3 will require full genome sequencing.
The HBoV4 cluster included six strains. The complete genome of one representative strain
(NI-385) was obtained (Genbank accession: FJ973561). The NS1 protein of HBoV4 (NI-385)
showed an average of 11 % divergence to HBoV2 and 25–27 % divergence to HBoV1 or
HBoV3 (Table 2C). For the VP1 protein, the relative divergences were reversed with an average
divergence of 8.5% relative to HBoV3, 9.5% compared to HBoV2, and 19% compared to
HBoV1. NI-385 therefore also appears to be a recombinant with the 5’ genes NS1 and NP1
most related to HBoV2 (particularly genotype A), while the 3’ VP1 slightly more similar to
HBoV3 than HBoV2 (Table 2C). According to ICTV species demarcation criteria in the genus
Bocavirus, members of different species must show greater than 5% divergence in their non-
structural gene nucleotide sequences (40). The genetic distance of NI-385 to its closest relatives
in the NS1 gene (HBoV2A) was 10.8% (range 6.8–12.6), indicating that NI-385 qualifies,
pending ICTV review, as the prototype of a fourth HBoV species (HBoV4). A distant VP1
(partial) variant of HBoV4 was also detected in the US (Fig.1 US-MN-964-05). To determine
if the latter variant represents a second HBoV4 genotype will require full genome sequencing.
Nearly complete genomes and phylogenetic analysis of new bocavirus species
In a manner similar to HBoV1 and 2, all the new genomes of HBoV2, 3, and 4 encoded three
large ORFs (Figure 5). The left ORF encodes the non-structural protein NS, the middle ORF
encodes NP1 and the right ORF encodes overlapping VP1/VP2 capsid proteins. Conserved
motifs associated with rolling circle replication, helicase and ATPase were identified within
the NS protein. NP1 is a highly phosphorylated protein of currently undetermined function
(41); NP1 differed in length between species, ranging from 214 to 219 aa. Situated within the
VP1-unique (VP1u) region the phospholipase A2 motifs required for parvovirus infectivity
were found in all 6 genomes, together with the presence of the calcium-binding loop and
catalytic residues.
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Further evidence of recombination in human bocaviruses
The six new HBoV genomes from this study were aligned with those of HBoV1, 2, and 3 from
prior studies. To determine the relationship between HBoV2 and other members of the
Bocavirus genus, phylogenetic analyses of NS1, NP1 and VP1/VP2 were performed, by use
of both nucleotide sequences and deduced protein sequences (Fig 2). NS1 and NP1 genes of
HBoV3 clustered with HBoV1 while their VP1/2 gene clustered with HBoV2. The
incongruence in phylogenetic association between loci provided further evidence that HBoV3
originated from a recombination event bringing together the NS1/NP1 gene of HBoV1 and the
VP1/2 gene of HBoV2 (8). The likely recombinant origin of HBoV4, clustering with HBoV2
in the NS1/NP1 but with HBoV3 in the VP1, is also shown.
A scan of sequence divergence between complete genome sequences further supported the
hypothesis of past recombination between HBoV1 and 2 in the generation of HBoV3 and of
HBoV2 and HBoV3 in the generation of HBoV4, with both recombination points near the NP1
and VP1 junction (Fig 3). When different HBoV2 variants were similarly analyzed for
recombination, intraspecies HBoV2 recombinants were also detected (data not shown and
(7))
Diversity amongst respiratory HBoV1 and enteric HBoV2-4
We compared the intra-species diversity of HBoV1 with that of HBoV2 using the partial VP1
sequence data generated with the pan-bocavirus PCR primers available for the greatest number
of HBoV2, 3, 4 variants (Fig 4A and 4B). A very low average pair-wise difference was seen
for HBoV1 collected world-wide (Fig. 4A). HBoV2, including both genotypes, was more
diversified than HBoV1 although HBoV2B alone showed a low level of diversity comparable
to that of HBoV1 (HBoV2B generated the large low divergence peak of figure 4B). The
homogeneity of HBoV1 and HBoV2B can also be visualized in the small branches length in
figure 1. When the pair-wise distances of all the enteric (non-HBoV1) sequences were plotted
the distribution was much larger than that for HBoV1 (Fig 4C). The low level of intra-species
diversity of HBoV1 relative to the other species is also reflected in Table 1B.
Splicing in NS
The genomic organization of HBoV species are remarkably similar to those of animal
bocaviruses, expect that all HBoV NS ORFs encode a shorter NS2 protein (630 to 650 aa)
compared to animal bocaviruses NS1 (716 to 726 aa) (Fig 5). We noticed in all four HBoV
species the presence of a stretch of encoded amino acids similar to the C-terminus of the longer
NS1 of animal bocaviruses overlapping the NP ORF but in a different frame (Fig 5). Genomes
of all HBoV species were aligned to determine the presence of conserved potential RNA
splicing signals near the end of the smaller NS2 ORF and the putative second exon encoding
the C-terminal region of NS1 (Fig 5). The putative NS1 resulting from such a spliced transcript
encoded a 750–780 amino acid long protein whose carboxy-termini showed significant
similarity to that of the canine and bovine bocaviruses NS1 (Fig 5)(42,43). A recent publication
using RT-PCR for the detection of HBoV1 viral transcript in human lung epithelial cells failed
to detect the NS splicing proposed here (44). On the other hand the proposed NS1 RNA splicing
and NS1 protein expression itself were detected using Northern blots and NS1 C-termini
specific sera respectively in 293 and human epithelial cells transfected with plasmids
expressing HBoV1 transcripts (Jianming Qiu, personal communication).
Human bocavirus 2–4 disease association
Most positive stool samples contained HBoV2B (76/101) making this genotype the most
commonly detected enteric human bocavirus (Table 1). HBoV3 was identified in 11 stool
samples and HBoV4 in 6 making them the second and third most common enteric human
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bocaviruses respectively in the regions analyzed here. Only four of the 101 positive samples
belonged to HBoV1. Stools from AFP cases from Nigeria and Tunisia both showed a high
prevalence of HBoV2A+B (21–26%). Since both AFP cases and healthy contacts from Tunisia
showed a comparable prevalence of HBoV2 no association was seen between AFP and HBoV2
shedding. The prevalence of HBoV2 in adults with diarrhea from the US and Nepal were also
compared to those in healthy matched subjects. No associations were observed between
HBoV2 shedding and diarrhea. While the numbers of HBoV3 and HBoV4 detected were
relatively small it was noticed that the eight HBoV3 and four HBoV4 were found only amongst
192 AFP samples while none was found among 96 healthy Tunisian matched contacts.
Comparing the combined Nigerian and Tunisia AFP infected with HBoV3 and HBoV4 to
Tunisian controls yielded a 2 tail Fisher’s exact p value of 0.01 while comparing only the
Tunisian AFP to Tunisian controls gave a p value of 0.059. HBoV3 was also found from one
case each of diarrhea from Nepal and the US and from one healthy person. HBoV4 was also
found in a diarrhea case and one healthy US adult. Further testing will be needed to confirm
this trend of an association of HBoV3/4 with AFP in children.
DISCUSSION
We report on a previously uncharacterized species of bocavirus we tentatively named HBoV4.
HBoV1 to HBoV3 were also detected by this pan-PCR approach. HBoV2 was recently
described in the stool of Pakistani children (7) and HBoV3 in stool samples of Australian
children (8) and both were recognized as recombinant viruses. The newly reported Australian
HBoV3 (EU918736) appears closely related to a Tunisian strain (TA-210-07)(Fig 2). A highly
prevalent genotype of HBoV2 (HBoV2B), together with partial genomic support for second
genotypes of HBoV3 and HBoV4, were also identified. The availability of novel bocavirus
genomes will allow the design of species specific PCR or microarray oligonucleotides for their
detection and disease association studies now required for the 3 recently characterized enteric
human bocavirus species (HBoV2,3,4). Based on the phylogenetic clustering observed for a
large number of partial VP1 sequences (Fig 1) and the distances among full genomes (Table
2) we propose for future classification that HBoV strains showing >8% protein and >10%
nucleotide difference in complete VP1 gene be considered different species while those
showing >1.5% protein and >5% nucleotide difference be considered as different genotypes.
Such VP1 based classification would retain the four proposed human bocavirus species. The
VP1 locus was selected since it is likely to strongly influence tissue tropism and potentially
pathogenesis (45).
HBoV1 is primarily, although not exclusively (29–34), a respiratory virus. We show here a
higher prevalence of HBoV2 (particularly HBoV2B) than HBoV1 in stool samples from
children of different countries. A study testing for HBoV1 and HBoV2 DNA using species
specific nested PCRs failed to detect any HBoV2 in >6500 respiratory secretion samples from
Edinburgh and Bangkok while HBoV1 was found in 3% and 14% of these respiratory samples
respectively (46). Another study found 5/212 (2%) nasopharyngeal samples from Korean
children with acute lower respiratory track infections to be positive for HBoV2 DNA while
unexpectedly no HBoV1 DNA was found (47). Analyzing for HBoV1 and HBoV2 in both
respiratory secretion and stool samples collected from the same individuals will be required to
confirm whether the tropism of HBoV2 favors the digestive track and is distinct from that of
the largely respiratory HBoV1.
Extensive evidence for recombination was observed through full genome analyses including
the likely recombinant origin of HBoV3 and HBoV4 and the high level of intra-species
recombination between HBoV2 variants (7,8). The high prevalence of bocavirus infection
provides the opportunity for co-infections, the first step in generating recombinant viruses.
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Indeed a HBoV3 and HBoV4 co-infection was detected based on the pattern of mixed bases
in one directly sequenced PCR product (data not shown).
The frequent detection of HBoVs in stool from both healthy children and adults support the
likelihood of long periods of viral shedding and/or frequent re-infections. Whether symptoms
such as diarrhea were associated with acute infection in subsequently healthy viral shedders
will require quantitative viral load measurements and analysis of longitudinally collected
samples. Whether prior infection provides any protection against re-infection with the same or
different genotype or species is also unknown.
A borderline statistical association of HBoV2 shedding with diarrhea was reported in
Australian children (8) requiring validation by larger studies. In both diarrhea sample sets
analyzed here, consisting mostly of adults, no association with HBoV2 shedding was detected.
If HBoV2 causes diarrhea, it may do so in only a small subset of infected children, possibly
those without passively transferred maternal antibodies or protective immune responses from
prior infections. Co-infections with other enteric viruses may also exacerbate symptoms. Given
the very large number of infections (viral shedding prevalence of >20% in some countries)
even low virulence could translate into a large disease burden.
A trend of an association of HBoV3/HBoV4 detection with AFP was detected. The small
numbers of cases will require independent confirmation. The neurological damages caused by
bovine and canine bocaviruses in their animal hosts provide a precedent for infant nervous
system pathogenicity.
The totality of HBoV1 sequences collected worldwide by multiple groups show very low
protein and nucleotide sequence diversity (35,36)(Table 2 and Fig 4). In contrast this single
study found substantial diversity among HBoV2 and HBoV3, a fourth species (HBoV4) and
extensive viral recombination. Assuming comparable rates of evolution, the genetically
homogeneous and largely respiratory HBoV1 therefore appears to be the more recently evolved
species relative to the more diverse HBoV2, 3, and 4 found predominantly in feces. We propose
that HBoV1 evolved from an enteric bocavirus ancestor that acquired, through mutation and/
or recombination, enhanced respiratory tract tropism. Single stranded DNA parvoviruses have
been shown to have a mutation rate approaching that of RNA viruses and recombination among
animal parvoviruses have been reported (48–51). Parvoviruses also have the demonstrated
capacity to rapidly expand their host species tropism resulting in a recent pandemic in dogs
(45,52,53). A recent study showed that HBoV1 could replicate in differentiated human airway
epithelial cells (44). Whether HBoV2, 3, and 4 show an in vitro tropism and in vivo distribution
that is more biased towards digestive track cells will require further studies.
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Figure 1.
Phylogenetic analysis of partial VP1 pan-bocavirus PCR amplicons of different species of
human bocaviruses. Tree constructed by neighbour-joining of pairwise maximum composite
likelihood distances between nucleotide sequences; bootstrap values ≥ 70% shown.
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Figure 2.
Phylogenetic analyses of nucleotide (upper panel) and inferred amino acid sequences of the
three principal open reading frames of HBoV1-4; bootstrap values ≥ 70% shown. The NS1
trees used HBoV sequences spliced as described.
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Figure 3.
HBoV3 and HBoV4 are recombinant genomes. Pair-wise Jukes-Cantor corrected distance
scans of HBoV3 and HBoV4 sequences against prespresentative sequences of HBoV1 and 2A,
or individual sequences as indicated in legend.
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Figure 4.
Representation of genetic diversity within and between different bocavirus species.
Distribution of pair-wise uncorrected p-distances in the partial VP1 region amplified using
pan-bocavirus PCR among A) HBoV1, B) HBoV2 and C) HBoV2-4 combined.
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Figure 5.
Evidence for RNA splicing in HBoVs genome to generate longer NS1 proteins. (A) proposed
genomic organization of HBoVs relative to that of animal bocaviruses. Black boxes represent
exon 2 of NS1 protein. (B) Canonical sequence of splice donor, branch site and splice acceptor
(Pu=A/G, Py=T/C). All HBoVs species were aligned to show presence of putative RNA
splicing elements in the NS exon. (c) region of highest similarity between extended carboxy-
termini of NS1 of HBoV1-4 species and termini of animal bocaviruses NS1. The amino acid
positions used in alignment are shown.
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